Treatment & Outcomes Data for Schizophrenia
This study is completed. It is testing treatment & Outcomes Data for Schizophrenia.
Location not clearly listedThis study is directly about Schizophrenia.

Compare studies and check their requirements with the research team.
This study is completed. It is testing treatment & Outcomes Data for Schizophrenia.
Location not clearly listedThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
In WuhanThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including AlbaThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
In KingstonThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In RomaniaThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In AustriaThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In GermanyThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In BelgiumThis study is directly about Schizophrenia.
This study is looking at whether Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 can help people with Serious mental illnesses including schizophrenia, bipolarity, and schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia, Bipolarity. Participants take part in Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 and complete follow-up assessments.
In United StatesThis study is directly about Schizophrenia.
This study is not recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
In TorontoThis study is directly about Schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.